“…T cells in cellular lesions express ANXA1 robustly, presumably due to widespread infl ammation, as indicated by accumulation of lymphohistiocytic and plasmacytic infi ltrate, edema, and absence of granuloma. ANXA1 has been described in the literature as a key regulator of T cell activation and migration to infl ammatory sites (29) (30) (33) , and of signaling pathways (p38, ERK MAPK, Akt, and NF-κB) that control production of cytokines such as TNF-α, INF-γ, IL-2, and IL-17 (37) (38) . ANXA1 also regulates the differentiation and proliferation of lymphocytes (18) .…”